Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00236171
Status:
COMPLETED
Last Update Posted:
2010-06-08
First Post:
2005-10-04
Brief Title:
Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test
Sponsor:
Technische Universität Dresden
Organization:
Technische Universität Dresden
Study Overview
Official Title:
Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test
Status:
COMPLETED
Status Verified Date:
2010-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy of the topical therapies Protopic and Advantan as well as their combination against placebo in a Psoriasis Plaque Test
Detailed Description:
daily psoriasis plaque tests for two weeks and optical coherence tomography OCT and 20-MHz-ultrasound on day 0 and day 11 10 days post end of treatment and 20 days post end of treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None